Comparison of complications after D2 and D3 dissection for gastric cancer

被引:0
作者
Bostanci, EB [1 ]
Yol, S [1 ]
Kayaalp, C [1 ]
Ozogul, Y [1 ]
Aydin, C [1 ]
Atalay, F [1 ]
Akoglu, M [1 ]
机构
[1] Turkiye Yuksek Ihtisas Hosp, Dept Gastrointestinal Surg, Ankara, Turkey
来源
EJSO | 2004年 / 30卷 / 01期
关键词
gastric cancer; gastrectomy; lymph node dissection; mortality; morbidity;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. D3 dissection is accepted as having higher rates of mortality and morbidity than D2 dissection. In this study, we aimed to evaluate the mortality and morbidity rates of D3 dissection in our department and to compare these with mortality and morbidity after D2 dissection. Patients and methods. All patients who underwent radical gastric resection with lymph node dissection for gastric adenocarcinoma between June 1999 and June 2002 were evaluated. Clinicopathologic features of the tumour, the resection and lymphadenectomy, the postoperative mortality and morbidity were analysed. Results. There were 359 patients admitted for the treatment of gastric cancer. One hundred twenty four underwent palliative resection and 134 underwent resection with curative intent. Of 34/134 patients, underwent gastric resection with D3 dissection, and 100 underwent D2 dissection. The overall operative mortality rate of D2 and D3 dissections was 1 and 8.8%, respectively (p < 0.05). The relaparotomy rate was almost doubled in D3 dissection group (11.8% vs. 6%) but this difference was not statistically significant. D3 dissection was also associated with an increase in morbidity (35.3% vs. 10%, p < 0.05). Conclusions. This study indicates that D3 dissection can be performed with reasonable safety. It may be a useful alternative procedure in advanced cases for which additional risks of surgical morbidity and mortality are felt to be outweighed by potential benefits to patients. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 50 条
  • [31] Operative and Oncological Outcomes After D2 Versus D1 Gastrectomy of Operable Gastric Cancer: an Observational Study
    Elmessiry, Mohamed M.
    El-Fayoumi, Tarek A.
    Fayed, Haytham M.
    Gebaly, Ahmed A.
    Mohamed, Eman A. E.
    JOURNAL OF GASTROINTESTINAL CANCER, 2022, 53 (01) : 91 - 98
  • [32] Comments to young surgeons concerning laparoscopic spleen-preserving D2 lymph node dissection for advanced gastric cancer on the upper body
    Choi, Yoon Young
    An, Ji Yeong
    Hyung, Woo Jin
    Noh, Sung Hoon
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (03) : 231 - 233
  • [33] Why should we perform a D2 lymphadenectomy in gastric cancer?
    Barreto, Savio George
    Sirohi, Bhawna
    FUTURE ONCOLOGY, 2017, 13 (23) : 2009 - 2012
  • [34] A prospective randomized clinical trial comparing D2 dissection in laparoscopic and open gastrectomy for gastric cancer
    Cui, Ming
    Li, Ziyu
    Xing, Jiadi
    Yao, Zhendan
    Liu, Maoxing
    Chen, Lei
    Zhang, Chenghai
    Yang, Hong
    Zhang, Nan
    Tan, Fei
    Jiang, Beihai
    Di, Jiabo
    Wang, Zaozao
    Ji, Jiafu
    Su, Xiangqian
    MEDICAL ONCOLOGY, 2015, 32 (10)
  • [35] Is D2 lymph node dissection necessary for early gastric cancer?
    Takaki Yoshikawa
    Akira Tsuburaya
    Osamu Kobayashi
    Motonori Sairenji
    Hisahiko Motohashi
    Yoshikazu Noguchi
    Annals of Surgical Oncology, 2002, 9 (4) : 401 - 405
  • [36] Is D2 lymph node dissection necessary for early gastric cancer?
    Yoshikawa, T
    Tsuburaya, A
    Kobayashi, O
    Sairenji, M
    Motohashi, H
    Noguchi, Y
    ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (04) : 401 - 405
  • [37] Evaluation of the recurrence pattern of gastric cancer after laparoscopic gastrectomy with D2 lymphadenectomy
    Kawamura, Yuichiro
    Satoh, Seiji
    Umeki, Yusuke
    Ishida, Yoshinori
    Suda, Koichi
    Uyama, Ichiro
    SPRINGERPLUS, 2016, 5
  • [38] Resected gastric cancer with D2 dissection: advances in adjuvant chemoradiotherapy and radiotherapy techniques
    Wu, Qiang
    Li, Guangjun
    Xu, Feng
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (06) : 703 - 713
  • [39] Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery
    Kung, C-H
    Tsai, J. A.
    Lundell, L.
    Johansson, J.
    Nilsson, M.
    Lindblad, M.
    BJS OPEN, 2020, 4 (03): : 424 - 431
  • [40] Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer
    Degiuli, M.
    Sasako, M.
    Ponti, A.
    Vendrame, A.
    Tomatis, M.
    Mazza, C.
    Borasi, A.
    Capussotti, L.
    Fronda, G.
    Morino, M.
    BRITISH JOURNAL OF SURGERY, 2014, 101 (02) : 23 - 31